Skip to main content
Erschienen in: Advances in Therapy 5/2016

28.04.2016 | Original Research

Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study

verfasst von: Jianjun Gu, Jiajie Zhai, Sheng Zhou, Jiaqi Chen

Erschienen in: Advances in Therapy | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The objective of this study was to report clinical outcomes (functional and anatomic) of Boston keratoprosthesis (KPro) after severe chemical burns in Southern China.

Methods

Nineteen patients (19 eyes) that sustained severe chemical injuries in Southern China were enrolled in this retrospective study in our hospital between May 2009 and June 2015. KPro implantation in these patients was performed by a single experienced surgeon (Jiaqi Chen). The parameters evaluated in this study included diagnosis, comorbidity, preoperative and postoperative visual acuity (VA), complications, KPro retention, histological and immunohistochemical results of retroprosthetic membrane (RPM) and mucous membrane over the optic cylinder.

Results

The mean age of the patients was 42.7 ± 11.3 years (range 29–62 years). All patients were male. Of the 19 included eyes, nine had acid burns, and 10 had alkali burns. Ten patients had previously undergone failed penetrating keratoplasty. The mean follow-up time was 41.3 ± 5.5 months (range 36–56 months). Preoperatively, the VA of the patients ranged from hand movement to light perception. Postoperatively, 17 patients (89.4%) achieved at least 20/200 once, and 7 patients (36.8%) achieved at least 20/200 and maintained this acuity until the last follow-up. The initial KPro was retained in 14 (73.6%) eyes and successfully replaced in one eye. Postoperative complications included RPM in 10 eyes, glaucoma in 6 eyes, retinal detachment in 2 eyes, corneal melting in 5 eyes, ischemic optic neuropathy in 1 eye, and overgrowth of the mucous membrane over the optical cylinder in 2 eyes. The histological and immunohistochemical results of the RPM showed granulomatous disorders and mucous membrane over the optic cylinder of conjunctival origin.

Conclusion

KPro surgery can restore useful vision in patients suffering from severe chemical burns. However, postoperative VA declined with the development of complications, and ocular surface disorders caused by the chemical burns were associated with a greater incidence of KPro retention failure. The retention rate was comparable in patients using ipsilateral autologous corneal tissue with allograft corneal tissue.

Funding

Science and Technology Foundation of Guangdong Province of China, Grant Number 2014A020212714.
Literatur
1.
Zurück zum Zitat Kramer SG. Late numerical grading of alkali burns to determine keratoplasty prognosis. Trans Am Ophthalmol Soc. 1983;81:97–106.PubMedPubMedCentral Kramer SG. Late numerical grading of alkali burns to determine keratoplasty prognosis. Trans Am Ophthalmol Soc. 1983;81:97–106.PubMedPubMedCentral
2.
Zurück zum Zitat Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997;41(4):275–313.CrossRefPubMed Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997;41(4):275–313.CrossRefPubMed
3.
Zurück zum Zitat Basu S, Mohamed A, Chaurasia S, et al. Clinical outcomes of penetrating keratoplastyafterautologouscultivatedlimbalepithelialtransplantation for ocular surface burns. Am J Ophthalmol. 2011;152(6):917–24.CrossRefPubMed Basu S, Mohamed A, Chaurasia S, et al. Clinical outcomes of penetrating keratoplastyafterautologouscultivatedlimbalepithelialtransplantation for ocular surface burns. Am J Ophthalmol. 2011;152(6):917–24.CrossRefPubMed
4.
Zurück zum Zitat Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye (Lond). 2009;23:1966–71.CrossRef Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye (Lond). 2009;23:1966–71.CrossRef
5.
Zurück zum Zitat Liang L, Sheha H, Tseng SC. Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. Arch Ophthalmol. 2009;127:1428–34.CrossRefPubMed Liang L, Sheha H, Tseng SC. Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. Arch Ophthalmol. 2009;127:1428–34.CrossRefPubMed
6.
Zurück zum Zitat Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116:640–51.CrossRefPubMed Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116:640–51.CrossRefPubMed
7.
Zurück zum Zitat Harissi-Dagher M, Dohlman CH. The Boston keratoprosthesis in severe ocular trauma. Can J Ophthalmol. 2008;43:165–9.CrossRefPubMed Harissi-Dagher M, Dohlman CH. The Boston keratoprosthesis in severe ocular trauma. Can J Ophthalmol. 2008;43:165–9.CrossRefPubMed
8.
Zurück zum Zitat Chen JQ, Zhai JJ, Gu JJ, et al. Preliminary study of Boston keratoprosthesis in treatment of severe late stage ocular chemical burns. Zhonghua Yan KezaZhi. 2012;48:537–41. Chen JQ, Zhai JJ, Gu JJ, et al. Preliminary study of Boston keratoprosthesis in treatment of severe late stage ocular chemical burns. Zhonghua Yan KezaZhi. 2012;48:537–41.
9.
Zurück zum Zitat Chan CC, Biber JM, Holland EJ. The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure. Cornea. 2012;31:1264–72.CrossRefPubMed Chan CC, Biber JM, Holland EJ. The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure. Cornea. 2012;31:1264–72.CrossRefPubMed
10.
11.
Zurück zum Zitat Liu C, Okera S, Tandon R, et al. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK. Br J Ophthalmol. 2008;92:1211–7.CrossRefPubMed Liu C, Okera S, Tandon R, et al. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK. Br J Ophthalmol. 2008;92:1211–7.CrossRefPubMed
12.
Zurück zum Zitat Dohlman CH, Harissi-Dagher M. Introduction to the use of the Boston keratoprosthesis. Expet Rev Ophthalmol. 2006;1:41–8.CrossRef Dohlman CH, Harissi-Dagher M. Introduction to the use of the Boston keratoprosthesis. Expet Rev Ophthalmol. 2006;1:41–8.CrossRef
13.
Zurück zum Zitat Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118:1543–50.CrossRefPubMed Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118:1543–50.CrossRefPubMed
14.
Zurück zum Zitat Cade F, Grosskreutz CL, Tauber A, et al. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea. 2011;30:1322–7.CrossRefPubMed Cade F, Grosskreutz CL, Tauber A, et al. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea. 2011;30:1322–7.CrossRefPubMed
15.
17.
Zurück zum Zitat Dohlman CH, Cade F, Pfister R. Chemical burns to the eye: paradigm shifts in treatment. Cornea. 2011;30:613–4.CrossRefPubMed Dohlman CH, Cade F, Pfister R. Chemical burns to the eye: paradigm shifts in treatment. Cornea. 2011;30:613–4.CrossRefPubMed
18.
Zurück zum Zitat Dohlman CH, Grosskreutz CL, Chen TC, et al. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J Glaucoma. 2010;19:111–5.CrossRefPubMed Dohlman CH, Grosskreutz CL, Chen TC, et al. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J Glaucoma. 2010;19:111–5.CrossRefPubMed
19.
Zurück zum Zitat Li JY, Greiner MA, Brandt JD, et al. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol. 2011;152:209–18.CrossRefPubMed Li JY, Greiner MA, Brandt JD, et al. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol. 2011;152:209–18.CrossRefPubMed
20.
Zurück zum Zitat Rivier D, Paula JS, Kim E, et al. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma. 2009;18:321–4.CrossRefPubMed Rivier D, Paula JS, Kim E, et al. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma. 2009;18:321–4.CrossRefPubMed
21.
Zurück zum Zitat Lin P, Wollstein G, Glavas IP, et al. Contact transscleral neodymium: yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome. Ophthalmology. 2004;111(11):2137–43.CrossRefPubMedPubMedCentral Lin P, Wollstein G, Glavas IP, et al. Contact transscleral neodymium: yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome. Ophthalmology. 2004;111(11):2137–43.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kammerdiener LL, Speiser JL, Aquavella JV, et al. Protective effect of soft contact lenses after Boston keratoprosthesis. Br J Ophthalmol. 2016;100(4):549–52.CrossRefPubMed Kammerdiener LL, Speiser JL, Aquavella JV, et al. Protective effect of soft contact lenses after Boston keratoprosthesis. Br J Ophthalmol. 2016;100(4):549–52.CrossRefPubMed
23.
Zurück zum Zitat Kiang L, Rosenblatt MI, Sartaj R, et al. Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization. Graefes Arch Clin Exp Ophthalmol. 2012;250:1195–9.CrossRefPubMedPubMedCentral Kiang L, Rosenblatt MI, Sartaj R, et al. Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization. Graefes Arch Clin Exp Ophthalmol. 2012;250:1195–9.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Khalifa YM, Davis D, Mamalis N, et al. Epithelial growth over the optic surface of the type 1 Boston Keratoprosthesis: histopathology and implications for biointegration. Clin Ophthalmol. 2010;4:1069–71.PubMedPubMedCentral Khalifa YM, Davis D, Mamalis N, et al. Epithelial growth over the optic surface of the type 1 Boston Keratoprosthesis: histopathology and implications for biointegration. Clin Ophthalmol. 2010;4:1069–71.PubMedPubMedCentral
25.
Zurück zum Zitat Ament JD, Todani A, Pineda R 2nd, et al. Global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol. 2010;149:537–9.CrossRefPubMed Ament JD, Todani A, Pineda R 2nd, et al. Global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol. 2010;149:537–9.CrossRefPubMed
26.
Zurück zum Zitat Robert M, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea. 2012;31:339–45.CrossRefPubMed Robert M, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea. 2012;31:339–45.CrossRefPubMed
27.
Zurück zum Zitat Akpek EK, Aldave AJ, Aquavella JV. The use of precut, gamma-irradiated corneal lenticules in Boston type 1 keratoprosthesis implantation. Am J Ophthalmol. 2012;154:e491.CrossRef Akpek EK, Aldave AJ, Aquavella JV. The use of precut, gamma-irradiated corneal lenticules in Boston type 1 keratoprosthesis implantation. Am J Ophthalmol. 2012;154:e491.CrossRef
28.
Zurück zum Zitat Ament JD, Tilahun Y, Mudawi E, et al. Role for ipsilateral autologous corneas as a carrier for the Boston keratoprosthesis: the Africa experience. Arch Ophthalmol. 2010;128:795–7.CrossRefPubMed Ament JD, Tilahun Y, Mudawi E, et al. Role for ipsilateral autologous corneas as a carrier for the Boston keratoprosthesis: the Africa experience. Arch Ophthalmol. 2010;128:795–7.CrossRefPubMed
29.
Zurück zum Zitat Cruzat A, Tauber A, Shukla A, et al. Low-cost and readily available tissue carriers for the Boston keratoprosthesis: a review of possibilities. J Ophthalmol. 2013;2013:1–5.CrossRef Cruzat A, Tauber A, Shukla A, et al. Low-cost and readily available tissue carriers for the Boston keratoprosthesis: a review of possibilities. J Ophthalmol. 2013;2013:1–5.CrossRef
30.
Zurück zum Zitat Yuan J, Chen JQ, Zhou SY, et al. The effects of transplantation of compound keratoprosthesis in clinical practice and managements of complications after operation. Zhonghua Yan Ke Za Zhi. 2009;45:104–9.PubMed Yuan J, Chen JQ, Zhou SY, et al. The effects of transplantation of compound keratoprosthesis in clinical practice and managements of complications after operation. Zhonghua Yan Ke Za Zhi. 2009;45:104–9.PubMed
31.
Zurück zum Zitat Palioura Sotiria, Chodosh James. Boston keratoprosthesis type II: indications, techniques, outcomes, and management. In: Cortina M, Cruz J, editors. Keratoprostheses and artificial corneas. Heidelberg: Springer; 2015. p. 169–80. Palioura Sotiria, Chodosh James. Boston keratoprosthesis type II: indications, techniques, outcomes, and management. In: Cortina M, Cruz J, editors. Keratoprostheses and artificial corneas. Heidelberg: Springer; 2015. p. 169–80.
32.
Zurück zum Zitat Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol. 2001;113:345–50.CrossRef Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol. 2001;113:345–50.CrossRef
Metadaten
Titel
Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study
verfasst von
Jianjun Gu
Jiajie Zhai
Sheng Zhou
Jiaqi Chen
Publikationsdatum
28.04.2016
Verlag
Springer Healthcare
Erschienen in
Advances in Therapy / Ausgabe 5/2016
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-016-0330-9

Weitere Artikel der Ausgabe 5/2016

Advances in Therapy 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.